Compounds > methionine sulfoximine
Page last updated: 2024-08-21

methionine sulfoximine and Prostatic Neoplasms

methionine sulfoximine has been researched along with Prostatic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canada, A; Herman, L; Kidd, K; Robertson, C; Trump, D1
Mulcahy, RT; Ripple, M; Wilding, G1
Stearns, ME; Tew, KD; Woodworth, A1

Other Studies

3 other study(ies) available for methionine sulfoximine and Prostatic Neoplasms

ArticleYear
Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:1

    Topics: Buthionine Sulfoximine; Cell Survival; Glutathione; Humans; Male; Melphalan; Methionine Sulfoximine; Prostatic Neoplasms; Tumor Cells, Cultured

1993
Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
    The Journal of urology, 1993, Volume: 150, Issue:1

    Topics: Antineoplastic Agents; Blotting, Western; Buthionine Sulfoximine; Cell Division; Dose-Response Relationship, Drug; Drug Resistance; Glutathione; Glutathione Transferase; Humans; Male; Melphalan; Methionine Sulfoximine; Prostatic Neoplasms; Tumor Cells, Cultured

1993
Relationship of glutathione depletion and inhibition of glutathione-S-transferase activity to the antimitotic properties of estramustine.
    Cancer treatment reports, 1986, Volume: 70, Issue:6

    Topics: Buthionine Sulfoximine; Cell Line; Cell Survival; Drug Synergism; Estramustine; Glutathione; Glutathione Transferase; Humans; Male; Metaphase; Methionine Sulfoximine; Mitosis; Mitotic Index; Nitrogen Mustard Compounds; Prostatic Neoplasms; Tumor Stem Cell Assay

1986